Filter
4391
Filtered Results: 4391
Text search:
drug
strategy
Featured
Recommendations
380
New Publications
1263
Language
Document type
No document type
2739
Studies & Reports
681
Guidelines
505
Manuals
166
Strategic & Response Plan
158
Fact sheets
53
Training Material
45
Situation Updates
22
Infographics
13
Resource Platforms
5
Brochures
2
Dashboards/Maps
1
App
1
Countries / Regions
India
223
Kenya
152
Global
145
Uganda
113
South Africa
112
Ethiopia
108
Western and Central Europe
100
Nigeria
94
Nepal
86
Liberia
82
Zambia
77
Sierra Leone
75
Malawi
74
Tanzania
73
Myanmar / Burma
72
Africa
66
Latin America and the Carribbean
66
Bangladesh
61
Ghana
58
Rwanda
53
Eastern Europe
49
Namibia
44
Ukraine
42
Philippines
41
Indonesia
40
Cambodia
37
Asia
37
Zimbabwe
36
South–East Asia Region
33
Lesotho
31
Botswana
25
Russia
24
Syria
23
Congo, Democratic Republic of
20
Colombia
18
Senegal
17
Mozambique
17
East and Southern Africa
16
Eswatini/ Swaziland
16
Burkina Faso
15
West and Central Africa
15
Brazil
15
Middle East and North Africa
14
South Sudan
13
Eastern Europe and Central Asia
12
Cameroon
11
Albania
11
Tajikistan
10
Thailand
10
USA
10
Venezuela
10
Pakistan
10
Guinea
9
Haiti
9
Sudan
9
Georgia
9
Germany
8
Peru
7
Western Pacific Region
7
Vietnam
7
Benin
6
Laos
6
Afghanistan
6
Argentina
6
Iraq
5
North Macedonia
4
Mexico
4
Turkey
4
China
4
Jordan
4
Southern Africa
4
Lebanon
4
Moldova
4
Sri Lanka
4
Yemen
4
Central African Republic
4
Timor Leste/ East Timor
3
El Salvador
3
Iran
3
Armenia
3
Paraguay
3
Jamaica
3
Bolivia
3
Bhutan
3
Somalia
3
Estonia
2
Kyrgyzstan
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
North America
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Honduras
2
Libya
2
Madagascar
2
North Korea
1
Switzerland
1
Serbia
1
Gambia
1
Kazakhstan
1
Chile
1
Canada
1
Fiji
1
Austria
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1792
Clinical Guidelines
384
Public Health
242
Women & Child Health
150
Key Resources
92
Capacity Building
51
Pharmacy & Technologies
44
Annual Report MEDBOX
1
Toolboxes
HIV
553
TB
454
Mental Health
337
AMR
238
COVID-19
168
NTDs
160
Pharmacy
109
NCDs
98
Rapid Response
79
Caregiver
71
Planetary Health
64
Ebola
63
Conflict
52
Global Health Education
48
Disability
47
Refugee
45
Health Financing Toolbox
31
Polio
21
Natural Hazards
17
Specific Hazards
14
Cholera
14
Zika
10
Social Ethics
9
Health Financing
1
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
Worldwide, there are about 17 million deaths due to cardiovascular disease (CVD) each year and at least two or three times as many non-fatal events. Raised cholesterol greatly increases the risks of stroke and heart disease, causing a large
health burden across the world. The World Health Organizat...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public health issue.
The World Health Organization (WHO) estimates that the number of cases reported worldwid...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Sexual abuse perpetrated against children is one of the most significant crises of our time. Child sexual abuse is a significant risk factor for children, in common with other forms of child maltreatment. Sexual abuse can have severe short- and long-term consequences on the physical, mental, social,...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
The purpose of this workbook is to assist ministries of health, health managers and practitioners in engaging with the private sector on delivery of quality maternal, newborn and child health (MNCH) services in lower- and middle-income countries. Private health care is one of the fastest growing seg...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progression towards universal health coverage.
This manual provides managers and others responsible for plan...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
